Profile
Executives
- Marc Koska, OBE, Co-Founder & Head of Product Design, ApiJect
- Jay Walker, Co-Founder, Executive Chairman & CEO, ApiJect
- Hanjin In, Partner & Board Member, ApiJect & CEO, Tae-Chang Industrial
- Molly Weaver, PhD, Chief Technology Officer, ApiJect
- Jon Ellenthal, President, ApiJect
- Peter Stone, Chief Financial Officer, Corporate Secretary & Treasurer, ApiJect
- Amy Stewart, Chief People Officer, ApiJect
- Ed Kelley, PhD, Chief Global Health Officer, ApiJect
- Bo Kowalczyk, Chief Commercial Officer, ApiJect
- Dana Gilland, Senior Vice President, ESG, ApiJect
Experts
- Philip Leslie, Acting Head of Manufacturing
- Josh Myers, Vice President, Distributed Manufacturing & Supply Chain
- Jeff Price, Consulting Principal BFS Engineer
- Jon Burgess, General Manager, Technology Development Center
- Lisa Fotheringham, Vice President, Project Management & Quality
- Dave Boerschel, Program Director, Blow-Fill-Seal
- Todd Gifford, Blow-Fill-Seal Operations and Training Manager
- Christian Eichhorn, Vice President, Packaging and Process Development
- Michael Buzecky, Director, Process Development & Packaging
- Stephanie Summe, Senior Director of Device Development
- Donovan Bort, Principal Product Development Engineer
- Lindsay Pierle, Device Engineering Lead
- Paul Rutter, MD, SVP, Clinical Affairs
- Nick Robinson, SVP Manufacturing & Supply Chain
- Tony Wasilewski, Vice President, Pharmaceutical Development Services
- Lauren Greenberg, Vice President, Device Development
As Chief Technology Officer, Dr. Weaver is responsible for ApiJect’s development of Blow-Fill-Seal injection devices and production of its initial device, a single-dose prefilled drug delivery system. She leads a dynamic team that aims for innovation in new design and continuous improvement on existing ones.
Dr. Weaver is a seasoned industry leader whose leadership and expertise spans strategy, product development, and execution across a broad range of drug delivery systems. This relevant experience has been applied in developing injectable technologies comprising self-injection devices and other injectable platforms, as well as to manage and launch products and commercialization of devices globally, including European and Asian markets.
She most recently served as Vice President for Containment Systems & Portfolio Management at West Pharmaceutical Services where she was responsible for elastomer and container R&D, product packaging and sterilization, and management of more than 30 projects across the full West portfolio of work, including partnership with commercial fill-finish operations. She previously worked at Becton Dickinson & Company and Unilife Medical Corporation. Dr. Weaver holds a Ph.D. in Mechanical Engineering Materials Science from Duke University, an ScB from Brown University, and has published research in top journals in her field.
